Search clinical trials for: non responder

Total 53571 results

Pfizer

Terminated

Efficacy And Safety Of PF-00885706 For The Relief Of Symptoms In Subjects With Gastro-esophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease

Brazil, Germany, Korea, Republic of, Belgium, Spain, Slovakia, France
Novartis

Completed

Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients Not Adequately Responding to Aliskiren Alone

Hypertension

Estonia, France, Iceland, India, Italy, Korea, Republic of, Lithuania, Spain, Venezuela
Centre de recherche du Centre hospitalier universitaire...

Unknown

Effects of Latanoprost, Bimatoprost and Travoprost in Patients With Latanoprost-resistant Glaucoma

Ocular Hypertension | Primary Glaucoma

Canada
Rambam Health Care Campus

Unknown

Low Intensity ShockWave Therapy for ED in Non Responders to PDE5i - a Double Blind Placebo Controlled Study (LI-ESWT)

Erectile Dysfunction

Israel
AstraZeneca

Completed

Generalized Anxiety Disorder Adjunct Study

Anxiety Disorders | Anxiety | Anxiety Neuroses | Anxiety States

United States
Ullevaal University Hospital
The Norwegian Council for Cardiovascular Diseases.; Ada and Hagbart Waages... and other collaborators

Completed

Aspirin Non-responsiveness and Clopidogrel Endpoint Trial. (ASCET)

Atherosclerosis | Angina Pectoris | Coronary Heart Disease

Norway
Foundation for Liver Research

Completed

Subcutaneous Continuous Infusion of Interferon Alfa-2b and Ribavirin in Hepatitis C Genotype 1 Nonresponders (SCIN-C)

Chronic Hepatitis C

Netherlands
Sheba Medical Center

Unknown

Clinical Trial to Assess Safety and Efficacy of Combination Therapy: Hydroxychloroquine, Pegylated Interferon Alpha-2a and Ribavirin in Chronic Hepatitis C Subjects Non-responders to the Standard of Care Therapy.

Chronic Hepatitis C
University Hospital, Basel, Switzerland

Completed

Chronic Hepatitis C Non-Responder Study With AdoMet and Betaine

Hepatitis C

Switzerland
Aga Khan University

Completed

Interferon-gamma With Interferon Alpha and Ribavirin for Hepatitis C Non-responders

Hepatitis C | Genotype 3 | Non-responders | Relapsers

Pakistan
Ziv Hospital
Hillel Yafe MC Hadera

Completed

Do Low High Density Lipoprotein (HDL) Levels Predict Treatment Outcome in Patients With Chronic Hepatitis C Viral Infection?

Chronic Hepatitis C Viral Infection

Israel
Zhejiang Cancer Hospital

Unknown

Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001)

Non-small Cell Lung Cancer

China
Massachusetts General Hospital
Eli Lilly and Company

Completed

Strattera Treatment in Children With ADHD Who Have Poor Response to Stimulant Therapy

ADHD

United States
InterMune

Completed

CIFN and IFN γ-1b With or Without Ribavirin for Treatment of Chronic Hepatitis C (Nonresponders)

Chronic Hepatitis C

United States
Maastricht University Medical Center

Unknown

Transcutaneous Electrical Nerve Stimulation (TENS) in Chronic Pain, Responders and Non-Responders?

Lower Back Pain | Neck Pain | Shoulder Pain

Netherlands
University of Calgary

Unknown

Intravenous Immunoglobulin (IVIG) for Resistant Neuropathic Pain

Neuropathic Pain

Canada
Hepasome Pharmaceuticals

Unknown

HDV-Interferon in the Treatment of Chronic Hepatitis C Nonresponders and Naive Hepatitis C Patients

Chronic Hepatitis C

India
SELARL du Dr Jacques BUVAT
Bayer

Completed

Co-Administering Testosterone With PDE5 Inhibitors in ED Patients Non Responders to PDE5 Inhibitors Alone

Erectile Dysfunction | Hypogonadism

France
GlaxoSmithKline

Completed

Immunogenicity and Reactogenicity of MPL Adjuvanted Recombinant Hepatitis B- Vaccine and Engerix™-B in Adult Non-Responders

Hepatitis B

Belgium
Beth Israel Medical Center
InterMune

Completed

Study of High Dosage CIFN Plus RBV for HCV Genotype 1 Infected Patients Who Are Nonresponders to Prior Therapy

Hepatitis C

United States
BioWest Therapeutics Inc

Completed

An Extension Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection

Hepatitis C, Chronic

Canada
Hadassah Medical Organization
XTL Biopharmaceuticals

Withdrawn

Safety, Tolerability and Efficacy of XTL 2125 in HCV-Infected Patients Who Are Interferon-Alpha Non-Responders or Relapsers

Chronic Hepatitis C Virus Infection

Israel
French National Agency for Research on AIDS and...
Hoffmann-La Roche; InterMune

Completed

Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C

Hepatitis C, Chronic

France
Fundació Institut de Recerca de l'Hospital de la...

Completed

Secondary Prophylaxis After Variceal Bleeding in Non-Responders (KT-2000)

Cirrhosis | Portal Hypertension | Gastrointestinal Hemorrhage

Spain
BioWest Therapeutics Inc

Completed

A Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection

Hepatitis C, Chronic

Canada
Foundation for Liver Research

Completed

Pegintron Induction Therapy in HCV Non-Responders

Hepatitis C

Netherlands
French National Agency for Research on AIDS and...
Schering-Plough

Terminated

Triple Therapy With Peg-Interferon Alfa-2b/Ribavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2b/Ribavirin for Previous Hepatitis C Virus (HCV) Non Responders

Hepatitis C, Chronic

France
Sandoz

Completed

A Multicenter Placebo-Controlled Double Blind Study to Evaluate the Efficacy and Safety of Sandostatin ( SMS 201-995 ) in Patients With Acquired Immunodeficiency Related Diarrhea Who Were Either "Responders" or "Non-Responders" in a Prior Placebo-Controlled Double-Blind Sandostatin Study.

HIV Infections | Diarrhea

United States
New York State Psychiatric Institute
Moi Teaching and Referral Hospital

Not yet recruiting

Mental Health Treatment to Improve Father Depression and Child Outcomes in Kenya

Depression | Alcohol Use, Unspecified | Father-Child Relations

Kenya
University of Louisville
The Craig H. Neilsen Foundation

Not yet recruiting

Noninvasive Spinal Stimulation to Restore Hand Function in Children With Spinal Cord Injury

Spinal Cord Injury Cervical
University of Iowa

Not yet recruiting

Role of Inflammation in Vascular Phenotype Associated With E-cigarette Use

Inflammation | Electronic Cigarette Use | Endothelial Dysfunction

United States
Yonsei University

Not yet recruiting

Exercise Program in Patients With Nontuberculous Mycobacterial Pulmonary Disease

Nontuberculous Mycobacterial Pulmonary Disease

Korea, Republic of
Pfizer

Not yet recruiting

Analysis of the Effectiveness and Safety of Lorlatinib in Untreated ALK-Positive NSCLC Patients in a French Real-World Context (LOREA)

ALK+ Non-Small-Cell Lung Carcinoma
Bristol-Myers Squibb

Recruiting

A Study to Evaluate First-line Ipilimumab + Nivolumab in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (FINN)

Non-small Cell Lung Cancer (NSCLC)

Italy
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Stroke Prevention In Ischemic Stroke With Covert Atrial Fibrillation (SPICAF)

Stroke | Ischemic Stroke | Atrial Fibrillation | Cerebral Infarction
University Hospital Schleswig-Holstein
German Federal Ministry of Education and Research; Gesellschaft für Therapieforschung... and other collaborators

Not yet recruiting

Efficacy and Safety of Oral Controlled-Ileocolonic-Release Nicotinamide (CICR-NAM)

Ulcerative Colitis, Unspecified
Bayer

Not yet recruiting

A Study to Learn How Safe BAY3283142 is When Taken as a Single Dose or as Multiple Doses in Healthy Chinese Participants

Chronic Kidney Disease | Healthy Volunteers | Non-proliferative Diabetic Retinopathy

China
Physio-Assist
Icadom; Clinact

Not yet recruiting

Long-term Evaluation of the SIMEOX Device at Home in Non-cystic Fibrosis Bronchiectasis (Home-BRAC)

Non-cystic Fibrosis Bronchiectasis

France, Réunion
Tianjin Medical University Cancer Institute and...

Recruiting

TACE Combined With Immune Checkpoint Inhibitors for Liver Malignant Tumors (TIKET)

Liver Metastases | Hepatocellular Carcinoma Non-resectable | Cholangiocarcinoma Non-resectable | Liver Malignant Tumors

China
Bnai Zion Medical Center

Not yet recruiting

Effectivity Gas Extraction to Prevent Anesthesiologists Waste Gas Exposure of Sevofluorane During Pediatric Induction

Unrecognized Condition
MedSIR

Not yet recruiting

Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal Subtype (PONTIAC)

Advanced Breast Cancer | Hormone Receptor Positive Breast Carcinoma | Advanced Breast Carcinoma
Malaghan Institute of Medical Research
Wellington Zhaotai Therapies Limited; BioOra Limited

Not yet recruiting

A Study of WZTL-002 CAR T-cells for Adults With Relapsed Large B-cell Lymphoma (ENABLE-2)

Primary Mediastinal Large B-cell Lymphoma (PMBCL) | Large B-cell Lymphoma | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Transformed Non-Hodgkin Lymphoma

New Zealand
Chengdu Zenitar Biomedical Technology Co., Ltd

Recruiting

A Phase IIa Clinical Study of Puesta Mesylate for Injection in Patients With T-Cell Lymphoma and Cutaneous T-Cell Lymphoma

Cutaneous T-cell Lymphoma (CTCL) | Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

China
ZimVie

Not yet recruiting

Evaluation of Safety and Effectiveness of Primary Hybrid Construct of Mobi-C and ACDF in the Treatment of Two-level Symptomatic Degenerative Disc Disease in the Cervical Spine.

Degenerative Disc Disease
Shenzhen TargetRx, Inc.
Sir Run Run Shaw Hospital

Not yet recruiting

TGRX-1942 Chinese Phase I for Advanced Solid Tumor and/or Relapsed/Refractory Hematologic Malignancies

Non Small Cell Lung Cancer | Advanced Solid Tumor | Hematologic Malignancy
Kocaeli University

Not yet recruiting

Nonpharmacological Method for Relief During Episiotomy Repair

Pain

Turkey
University of Campania "Luigi Vanvitelli"
Cardarelli Hospital

Recruiting

Environmental Pollutants in COPD and Lung Cancer

COPD and Lung Cancer

Italy
Second Affiliated Hospital of Guangzhou Medical...

Recruiting

Checkpoint Inhibitor Combinations Therapy as First Line for Inoperable Lung Cancer Via IT

Lung Cancer | Inoperable Disease

China
Axter Therapeutics (Beijing) Co., Ltd

Not yet recruiting

Study of AXT-1003 in Subjects With Advanced Malignant Tumors.

Non-Hodgkin Lymphoma | Advanced Solid Tumor

China
Wuhan Union Hospital, China

Not yet recruiting

Fruquintinib and Pirfenidone in Combination With Anti-PD-1 Antibody in Advanced or Metastatic pMMR/MSS Colorectal Carcinoma

To Evaluate the Efficacy of Fruquintinib and Pirfenidone in Combination With Anti-PD-1 Antibody in Colorectal Carcinoma | To Evaluate Whether Pirfenidone Can Reshape the Tumor Microenvironment in Colorectal Cancer | Combination of Fruquintinib and Anti-PD-1 Antibody Was Reported to...

Search clinical trials for: non responder

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Norway

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations